We demonstrate that WNT5A mutations correlate with outcomes in colorectal cancer and find that, contrary to expectations, mutations do not impact WNT ligand binding to their respective receptors but instead appear to influence the dynamics and flexibility of the proteins. The gene discussed is WNT5A; the disease is colorectal cancer.